Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Incyte 1.674, Abbott Laboratories 12.593.
Incyte vs Abbott Laboratories: Revenue Comparison
Incyte (INCY) and Abbott Laboratories (ABT) are peers in Healthcare. Incyte reported revenue of $1.7B as of Q2 2026, compared with $12.6B for Abbott Laboratories. Abbott Laboratories leads on revenue.
Incyte's gross margin is 93.7% versus 58.0% for Abbott Laboratories. Incyte's net margin is 35.0% versus 7.4% for Abbott Laboratories.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Incyte, Abbott Laboratories.| Metric | Incyte | Abbott Laboratories |
|---|---|---|
| Market Cap | - | - |
| Revenue | $1.67B | $12.59B |
| Cost of Revenue | $105.00M | $5.29B |
| Gross Profit | $1.57B | $7.30B |
| Operating Income | $698.00M | $1.78B |
| Net Income | $586.00M | $928.00M |
| R&D Expense | $517.00M | $882.00M |
| Earnings Per Share | $2.81 | $0.53 |
| Gross Margin | 93.7% | 58.0% |
| Operating Margin | 41.7% | 14.2% |
| Net Profit Margin | 35.0% | 7.4% |
| Free Cash Flow | $495.00M | $2.89B |
| Cumulative Free Cash Flow | $3.86B | $142.48B |
| Operating Cash Flow | $508.00M | $2.49B |
| Cash & Equivalents | $3.98B | $5.10B |